Rapid and ecofriendly UPLC quantification of Remdesivir, Favipiravir and Dexamethasone for accurate therapeutic drug monitoring in Covid-19 Patient’s plasma

Innovative therapeutic protocols to the rapidly spreading coronavirus disease (COVID19) epidemic is highly required all across the world. As demonstrated by clinical studies, Favipiravir (FVP) and Remdesivir (REM) are new antiviral medicines that are effective against COVID-19. REM is the first FDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Emam, Aml A., Abdelaleem, Eglal A., Abdelmomen, Esraa H., Abdelmoety, Refaat H., Abdelfatah, Rehab M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098531/
https://www.ncbi.nlm.nih.gov/pubmed/35582001
http://dx.doi.org/10.1016/j.microc.2022.107580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098531/
https://www.ncbi.nlm.nih.gov/pubmed/35582001
http://dx.doi.org/10.1016/j.microc.2022.107580

Ejemplares similares